311 related articles for article (PubMed ID: 30794870)
1. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
Steiner D; Finke JH; Kwade A
Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
[TBL] [Abstract][Full Text] [Related]
2. Efficient production of nanoparticle-loaded orodispersible films by process integration in a stirred media mill.
Steiner D; Finke JH; Kwade A
Int J Pharm; 2016 Sep; 511(2):804-13. PubMed ID: 27477101
[TBL] [Abstract][Full Text] [Related]
3. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
Speer I; Preis M; Breitkreutz J
Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
[TBL] [Abstract][Full Text] [Related]
4. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
Speer I; Lenhart V; Preis M; Breitkreutz J
Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
[TBL] [Abstract][Full Text] [Related]
5. SOFTs - Structured orodispersible film templates.
Steiner D; Finke JH; Kwade A
Eur J Pharm Biopharm; 2019 Apr; 137():209-217. PubMed ID: 30836181
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on disintegration methods for oral film preparations.
Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
[TBL] [Abstract][Full Text] [Related]
7. Embedding of Poorly Water-Soluble Drugs in Orodispersible Films-Comparison of Five Formulation Strategies.
Steiner D; Tidau M; Finke JH
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678646
[TBL] [Abstract][Full Text] [Related]
8. Instant ODFs - Development of an intermediate, nanoparticle-based product platform for individualized medication.
Steiner D; Finke JH; Kwade A
Eur J Pharm Biopharm; 2018 May; 126():149-158. PubMed ID: 28414191
[TBL] [Abstract][Full Text] [Related]
9. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of an orodispersible film containing drug nanoparticles.
Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
[TBL] [Abstract][Full Text] [Related]
11. Semi-solid extrusion 3D printing ODFs: an individual drug delivery system for small scale pharmacy.
Yan TT; Lv ZF; Tian P; Lin MM; Lin W; Huang SY; Chen YZ
Drug Dev Ind Pharm; 2020 Apr; 46(4):531-538. PubMed ID: 32141352
[TBL] [Abstract][Full Text] [Related]
12. Anti-solvent Precipitation Method Coupled Electrospinning Process to Produce Poorly Water-Soluble Drug-Loaded Orodispersible Films.
Song Q; Guo X; Sun Y; Yang M
AAPS PharmSciTech; 2019 Aug; 20(7):273. PubMed ID: 31385126
[TBL] [Abstract][Full Text] [Related]
13. Novel Dissolution Method for Oral Film Preparations with Modified Release Properties.
Speer I; Preis M; Breitkreutz J
AAPS PharmSciTech; 2018 Dec; 20(1):7. PubMed ID: 30560468
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous silica nanoparticles facilitating the dissolution of poorly soluble drugs in orodispersible films.
Ṣen Karaman D; Patrignani G; Rosqvist E; Smått JH; Orłowska A; Mustafa R; Preis M; Rosenholm JM
Eur J Pharm Sci; 2018 Sep; 122():152-159. PubMed ID: 29966736
[TBL] [Abstract][Full Text] [Related]
15. Disintegration time of orally dissolving films: various methodologies and
Saab M; Mehanna MM
Pharmazie; 2019 Apr; 74(4):227-230. PubMed ID: 30940306
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on novel test systems to determine disintegration time of orodispersible films.
Preis M; Gronkowsky D; Grytzan D; Breitkreutz J
J Pharm Pharmacol; 2014 Aug; 66(8):1102-11. PubMed ID: 24673551
[TBL] [Abstract][Full Text] [Related]
17. Effect of surfactants and drug load on physico-mechanical and dissolution properties of nanocrystalline tadalafil-loaded oral films.
Vuddanda PR; Montenegro-Nicolini M; Morales JO; Velaga S
Eur J Pharm Sci; 2017 Nov; 109():372-380. PubMed ID: 28823854
[TBL] [Abstract][Full Text] [Related]
18. Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.
Cupone IE; Dellera E; Marra F; Giori AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322282
[TBL] [Abstract][Full Text] [Related]
19. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
Thabet Y; Lunter D; Breitkreutz J
Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
[TBL] [Abstract][Full Text] [Related]
20. Formulation Optimization and in Vitro Characterization of Orally Disintegrating Films Using a Factorial Design and Mathematical Modeling for Drug Release.
Lee Y; Thapa P; Jeong SH; Woo MH; Choi DH
Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):166-177. PubMed ID: 27904030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
